Xencor

XNCRNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.547 B

$20.81 +4.05%

Close of 7 Aug 2026

Revenue

$125.6M

#2446 by revenue

Earnings

-$91.9M

Loss-making

Shares outstanding

74,353,397

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#135First Tracks BiotherapeuticsTRAX$1.58B
#136Forte BiosciencesFBRX$1.57B
#137XencorXNCR$1.55B
#138HarrowHROW$1.51B
#139Avalyn PharmaAVLN$1.50B

Where these numbers come from

Share counts and financials for Xencor are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.